ARCHIVES

News Analysis: Industry’s Accelerated Recovery Initiative May Push Manufacturers Toward Collusion

This article is from The Cancer Letter archive.

Vol. 38 No. 37 | October 5, 2012

Download PDF Visit The Full Archive

Related Articles

Cancer Groups Criticize Prescription Drug Bills.

June 27, 2003

Scripps, Sandoz Deal Becomes Case Study As NI Rethinks Sponsored Research

January 28, 1994

Science Agencies Seek To Measure Effect Of Research Funding

June 4, 2010

Obey Aide Objects To Criticism Over Earmarking New NCI Positions

August 13, 1976

Reimbursement: NCI, VA Begin Project On Clinical Trials Access For Veterans

January 17, 1997

NCIs FY95 Bypass To Justify $3.47 Billion, includes $490 million For Breast Cancer Research

May 14, 1993